Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus lamotrigine and carbamazepine in newly diagnosed elderly patients with focal epilepsy
ISRCTN94839639Phase 4Completed
- Sponsor
- University Medical Center Mainz
- Start
- Oct 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Focal Onset Epilepsy comparing Levetiracetam, Carbamazepine and Lamotrigine (3 arms). Primary endpoint: 58-week retention rate. Started Oct 2006; status: completed.
02
Drugs
levetiracetamlamotriginecarbamazepine
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on ISRCTN94839639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN94839639.